ID   GBA2_HUMAN              Reviewed;         927 AA.
AC   Q9HCG7; D3DRP2; Q5TCV6; Q96A51; Q96LY1; Q96SJ2; Q9H2L8;
DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 2.
DT   10-MAY-2017, entry version 122.
DE   RecName: Full=Non-lysosomal glucosylceramidase;
DE            Short=NLGase;
DE            EC=3.2.1.45;
DE   AltName: Full=Beta-glucocerebrosidase 2;
DE            Short=Beta-glucosidase 2;
DE   AltName: Full=Glucosylceramidase 2;
GN   Name=GBA2; Synonyms=KIAA1605; ORFNames=AD035;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 39-46;
RP   619-636 AND 919-927, ENZYME ACTIVITY, AND TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=11489889; DOI=10.1074/jbc.M104290200;
RA   Matern H., Boermans H., Lottspeich F., Matern S.;
RT   "Molecular cloning and expression of human bile acid beta
RT   -glucosidase.";
RL   J. Biol. Chem. 276:37929-37933(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes.
RT   XVIII. The complete sequences of 100 new cDNA clones from brain which
RT   code for large proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-780 (ISOFORM 3).
RC   TISSUE=Adrenal gland;
RA   Xu X., Yang Y., Gao G., Xiao H., Chen Z., Han Z.;
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9111029; DOI=10.1074/jbc.272.17.11261;
RA   Matern H., Heinemann H., Legler G., Matern S.;
RT   "Purification and characterization of a microsomal bile acid beta-
RT   glucosidase from human liver.";
RL   J. Biol. Chem. 272:11261-11267(1997).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TOPOLOGY.
RX   PubMed=17105727; DOI=10.1074/jbc.M610544200;
RA   Boot R.G., Verhoek M., Donker-Koopman W., Strijland A., van Marle J.,
RA   Overkleeft H.S., Wennekes T., Aerts J.M.F.G.;
RT   "Identification of the non-lysosomal glucosylceramidase as beta-
RT   glucosidase 2.";
RL   J. Biol. Chem. 282:1305-1312(2007).
RN   [11]
RP   FUNCTION, AND VARIANT SPG46 TRP-630.
RX   PubMed=23332916; DOI=10.1016/j.ajhg.2012.11.021;
RA   Martin E., Schuele R., Smets K., Rastetter A., Boukhris A.,
RA   Loureiro J.L., Gonzalez M.A., Mundwiller E., Deconinck T., Wessner M.,
RA   Jornea L., Oteyza A.C., Durr A., Martin J.J., Schoels L., Mhiri C.,
RA   Lamari F., Zuechner S., De Jonghe P., Kabashi E., Brice A.,
RA   Stevanin G.;
RT   "Loss of function of glucocerebrosidase GBA2 is responsible for motor
RT   neuron defects in hereditary spastic paraplegia.";
RL   Am. J. Hum. Genet. 92:238-244(2013).
RN   [12]
RP   VARIANT SPG46 HIS-873.
RX   PubMed=23332917; DOI=10.1016/j.ajhg.2012.12.012;
RA   Hammer M.B., Eleuch-Fayache G., Schottlaender L.V., Nehdi H.,
RA   Gibbs J.R., Arepalli S.K., Chong S.B., Hernandez D.G., Sailer A.,
RA   Liu G., Mistry P.K., Cai H., Shrader G., Sassi C., Bouhlal Y.,
RA   Houlden H., Hentati F., Amouri R., Singleton A.B.;
RT   "Mutations in GBA2 cause autosomal-recessive cerebellar ataxia with
RT   spasticity.";
RL   Am. J. Hum. Genet. 92:245-251(2013).
CC   -!- FUNCTION: Non-lysosomal glucosylceramidase that catalyzes the
CC       conversion of glucosylceramide (GlcCer) to free glucose and
CC       ceramide. Involved in sphingomyelin generation and prevention of
CC       glycolipid accumulation. May also catalyze the hydrolysis of bile
CC       acid 3-O-glucosides, however, the relevance of such activity is
CC       unclear in vivo. Plays a role in central nevous system
CC       development. Required for proper formation of motor neuron axons.
CC       {ECO:0000269|PubMed:17105727, ECO:0000269|PubMed:23332916}.
CC   -!- CATALYTIC ACTIVITY: D-glucosyl-N-acylsphingosine + H(2)O = D-
CC       glucose + N-acylsphingosine. {ECO:0000269|PubMed:11489889}.
CC   -!- ENZYME REGULATION: Enzymatic activity is dependent on membrane
CC       association and requires the presence of lipids. {ECO:0000250}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.7 uM for 3-beta-D-glucosido-lithocholic
CC         {ECO:0000269|PubMed:9111029};
CC         KM=6.2 uM for 3-beta-D-glucosido-chenodeoxycholic
CC         {ECO:0000269|PubMed:9111029};
CC         KM=210 uM for beta-D-glucoside {ECO:0000269|PubMed:9111029};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250}; Peripheral membrane protein {ECO:0000250};
CC       Cytoplasmic side {ECO:0000250}. Golgi apparatus membrane
CC       {ECO:0000250}; Peripheral membrane protein {ECO:0000250};
CC       Cytoplasmic side {ECO:0000250}. Note=Not localized to lipid rafts.
CC       {ECO:0000269|PubMed:17105727}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9HCG7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HCG7-2; Sequence=VSP_024384;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9HCG7-3; Sequence=VSP_024383;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highly expressed in brain,
CC       heart, skeletal muscle, kidney and placenta and expressed at lower
CC       level in liver. {ECO:0000269|PubMed:11489889}.
CC   -!- DISEASE: Spastic paraplegia 46, autosomal recessive (SPG46)
CC       [MIM:614409]: A neurodegenerative disorder characterized by onset
CC       in childhood of slowly progressive spastic paraplegia and
CC       cerebellar signs. Some patients have cognitive impairment,
CC       cataracts, and cerebral, cerebellar, and corpus callosum atrophy
CC       on brain imaging. {ECO:0000269|PubMed:23332916,
CC       ECO:0000269|PubMed:23332917}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the non-lysosomal glucosylceramidase
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG44660.1; Type=Frameshift; Positions=649, 691; Evidence={ECO:0000305};
CC       Sequence=BAB13431.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ309567; CAC83792.1; -; mRNA.
DR   EMBL; AB046825; BAB13431.1; ALT_INIT; mRNA.
DR   EMBL; AK027884; BAB55430.1; -; mRNA.
DR   EMBL; AL834306; CAD38976.1; -; mRNA.
DR   EMBL; AL133410; CAI10981.1; -; Genomic_DNA.
DR   EMBL; AL133410; CAI10982.1; -; Genomic_DNA.
DR   EMBL; AL133410; CAI10983.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58348.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58349.1; -; Genomic_DNA.
DR   EMBL; BC011363; AAH11363.1; -; mRNA.
DR   EMBL; AF258662; AAG44660.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS6589.1; -. [Q9HCG7-1]
DR   CCDS; CCDS83363.1; -. [Q9HCG7-2]
DR   RefSeq; NP_001317589.1; NM_001330660.1. [Q9HCG7-2]
DR   RefSeq; NP_065995.1; NM_020944.2. [Q9HCG7-1]
DR   RefSeq; XP_016870435.1; XM_017014946.1. [Q9HCG7-3]
DR   UniGene; Hs.443134; -.
DR   ProteinModelPortal; Q9HCG7; -.
DR   SMR; Q9HCG7; -.
DR   BioGrid; 121728; 10.
DR   IntAct; Q9HCG7; 11.
DR   MINT; MINT-6630061; -.
DR   STRING; 9606.ENSP00000367343; -.
DR   BindingDB; Q9HCG7; -.
DR   ChEMBL; CHEMBL3761; -.
DR   SwissLipids; SLP:000001382; -.
DR   CAZy; GH116; Glycoside Hydrolase Family 116.
DR   iPTMnet; Q9HCG7; -.
DR   PhosphoSitePlus; Q9HCG7; -.
DR   BioMuta; GBA2; -.
DR   DMDM; 143018392; -.
DR   EPD; Q9HCG7; -.
DR   MaxQB; Q9HCG7; -.
DR   PaxDb; Q9HCG7; -.
DR   PeptideAtlas; Q9HCG7; -.
DR   PRIDE; Q9HCG7; -.
DR   Ensembl; ENST00000378094; ENSP00000367334; ENSG00000070610. [Q9HCG7-2]
DR   Ensembl; ENST00000378103; ENSP00000367343; ENSG00000070610. [Q9HCG7-1]
DR   GeneID; 57704; -.
DR   KEGG; hsa:57704; -.
DR   UCSC; uc003zxw.3; human. [Q9HCG7-1]
DR   CTD; 57704; -.
DR   DisGeNET; 57704; -.
DR   GeneCards; GBA2; -.
DR   HGNC; HGNC:18986; GBA2.
DR   HPA; HPA024026; -.
DR   MalaCards; GBA2; -.
DR   MIM; 609471; gene.
DR   MIM; 614409; phenotype.
DR   neXtProt; NX_Q9HCG7; -.
DR   OpenTargets; ENSG00000070610; -.
DR   Orphanet; 352641; Autosomal recessive cerebellar ataxia with late-onset spasticity.
DR   Orphanet; 320391; Autosomal recessive spastic paraplegia type 46.
DR   PharmGKB; PA38773; -.
DR   eggNOG; KOG2119; Eukaryota.
DR   eggNOG; COG4354; LUCA.
DR   GeneTree; ENSGT00390000010998; -.
DR   HOVERGEN; HBG105975; -.
DR   InParanoid; Q9HCG7; -.
DR   KO; K17108; -.
DR   OMA; VYYRRYT; -.
DR   OrthoDB; EOG091G01JK; -.
DR   PhylomeDB; Q9HCG7; -.
DR   TreeFam; TF313888; -.
DR   BRENDA; 3.2.1.45; 2681.
DR   Reactome; R-HSA-1660662; Glycosphingolipid metabolism.
DR   SABIO-RK; Q9HCG7; -.
DR   ChiTaRS; GBA2; human.
DR   GeneWiki; GBA2; -.
DR   GenomeRNAi; 57704; -.
DR   PRO; PR:Q9HCG7; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000070610; -.
DR   CleanEx; HS_GBA2; -.
DR   ExpressionAtlas; Q9HCG7; baseline and differential.
DR   Genevisible; Q9HCG7; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; TAS:UniProtKB.
DR   GO; GO:0008422; F:beta-glucosidase activity; IDA:UniProtKB.
DR   GO; GO:0004348; F:glucosylceramidase activity; TAS:Reactome.
DR   GO; GO:0008206; P:bile acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0021954; P:central nervous system neuron development; IMP:UniProtKB.
DR   GO; GO:0006680; P:glucosylceramide catabolic process; IEA:InterPro.
DR   GO; GO:0016139; P:glycoside catabolic process; IDA:UniProtKB.
DR   GO; GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome.
DR   InterPro; IPR008928; 6-hairpin_glycosidase-like.
DR   InterPro; IPR014551; B_Glucosidase_GBA2-typ.
DR   InterPro; IPR006775; GH116_catalytic.
DR   InterPro; IPR024462; GH116_N.
DR   Pfam; PF04685; DUF608; 1.
DR   Pfam; PF12215; Glyco_hydr_116N; 1.
DR   PIRSF; PIRSF028944; Beta_gluc_GBA2; 1.
DR   SUPFAM; SSF48208; SSF48208; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Direct protein sequencing;
KW   Disease mutation; Endoplasmic reticulum; Glycosidase; Golgi apparatus;
KW   Hereditary spastic paraplegia; Hydrolase; Lipid metabolism; Membrane;
KW   Neurodegeneration; Reference proteome; Sphingolipid metabolism.
FT   CHAIN         1    927       Non-lysosomal glucosylceramidase.
FT                                /FTId=PRO_0000283758.
FT   VAR_SEQ       1    287       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.8}.
FT                                /FTId=VSP_024383.
FT   VAR_SEQ     836    927       GLTWEGFQTAEGCYRTVWERLGLAFQTPEAYCQQRVFRSLA
FT                                YMRPLSIWAMQLALQQQQHKKASWPKVKQGTGLRTGPMFGP
FT                                KEAMANLSPE -> LLPSGFCLWVIVISSTCWELLEGKDST
FT                                ASIYPVEVALQRVPS (in isoform 2).
FT                                {ECO:0000303|PubMed:10997877}.
FT                                /FTId=VSP_024384.
FT   VARIANT     630    630       R -> W (in SPG46; dbSNP:rs398123012).
FT                                {ECO:0000269|PubMed:23332916}.
FT                                /FTId=VAR_069634.
FT   VARIANT     873    873       R -> H (in SPG46; dbSNP:rs398123015).
FT                                {ECO:0000269|PubMed:23332917}.
FT                                /FTId=VAR_069635.
FT   CONFLICT     60     60       C -> Y (in Ref. 3; BAB55430).
FT                                {ECO:0000305}.
FT   CONFLICT    222    222       C -> R (in Ref. 3; BAB55430).
FT                                {ECO:0000305}.
FT   CONFLICT    482    482       N -> K (in Ref. 3; BAB55430).
FT                                {ECO:0000305}.
SQ   SEQUENCE   927 AA;  104649 MW;  1F6879D6E20A2B1D CRC64;
     MGTQDPGNMG TGVPASEQIS CAKEDPQVYC PEETGGTKDV QVTDCKSPED SRPPKETDCC
     NPEDSGQLMV SYEGKAMGYQ VPPFGWRICL AHEFTEKRKP FQANNVSLSN MIKHIGMGLR
     YLQWWYRKTH VEKKTPFIDM INSVPLRQIY GCPLGGIGGG TITRGWRGQF CRWQLNPGMY
     QHRTVIADQF TVCLRREGQT VYQQVLSLER PSVLRSWNWG LCGYFAFYHA LYPRAWTVYQ
     LPGQNVTLTC RQITPILPHD YQDSSLPVGV FVWDVENEGD EALDVSIMFS MRNGLGGGDD
     APGGLWNEPF CLERSGETVR GLLLHHPTLP NPYTMAVAAR VTAATTVTHI TAFDPDSTGQ
     QVWQDLLQDG QLDSPTGQST PTQKGVGIAG AVCVSSKLRP RGQCRLEFSL AWDMPRIMFG
     AKGQVHYRRY TRFFGQDGDA APALSHYALC RYAEWEERIS AWQSPVLDDR SLPAWYKSAL
     FNELYFLADG GTVWLEVLED SLPEELGRNM CHLRPTLRDY GRFGYLEGQE YRMYNTYDVH
     FYASFALIML WPKLELSLQY DMALATLRED LTRRRYLMSG VMAPVKRRNV IPHDIGDPDD
     EPWLRVNAYL IHDTADWKDL NLKFVLQVYR DYYLTGDQNF LKDMWPVCLA VMESEMKFDK
     DHDGLIENGG YADQTYDGWV TTGPSAYCGG LWLAAVAVMV QMAALCGAQD IQDKFSSILS
     RGQEAYERLL WNGRYYNYDS SSRPQSRSVM SDQCAGQWFL KACGLGEGDT EVFPTQHVVR
     ALQTIFELNV QAFAGGAMGA VNGMQPHGVP DKSSVQSDEV WVGVVYGLAA TMIQEGLTWE
     GFQTAEGCYR TVWERLGLAF QTPEAYCQQR VFRSLAYMRP LSIWAMQLAL QQQQHKKASW
     PKVKQGTGLR TGPMFGPKEA MANLSPE
//
